Mechanisms of axonal spheroid formation in central nervous system wallerian degeneration

Journal of Neuropathology and Experimental Neurology

Volumn 69, Issue 5, 2010, Pages 455-472

  Beirowski, Bogdan ^a   Nógrádi, Antal ^b   Babetto, Elisabetta ^a   Garcia Alias, Guillermo ^c   Coleman, Michael P ^a,c  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Axon; Axonal degeneration; Axonal transport; Neuroaxonal dystrophy; Neurodegeneration; Neuroprotection

Indexed keywords

BRAIN PROTEIN; CALCIUM; UNCLASSIFIED DRUG; WALLERIAN DEGENERATION SLOW GENE;

ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CALCIUM CELL LEVEL; CELL LOSS; CELL SWELLING; CENTRAL NERVOUS SYSTEM DISEASE; CORPUS CALLOSUM; EX VIVO STUDY; GENE EXPRESSION; GROWTH INHIBITION; IN VIVO STUDY; MOLECULAR MECHANICS; MOUSE; NERVE DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; OPTIC NERVE; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SPHEROID CELL; SPINAL CORD DORSAL HORN; ULTRASTRUCTURE;

ADENINE; ANIMALS; AXONS; AXOTOMY; CALCIMYCIN; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; IONOPHORES; LUMINESCENT PROTEINS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; OPTIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; TIME FACTORS; WALLERIAN DEGENERATION;

EID: 77951880455     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181da84db     Document Type: Article

References (100)

1. Waller A. Experiments on the section of glossopharyngeal and hypoglossal nerves of the frog and observations of the alternatives produced thereby in the structure of their primitive fibres. Philos Trans R Soc Lond B Biol Sci 1850;140:423-429
2. Raff MC, Whitmore AV, Finn JT. Axonal self-destruction and neuro-degeneration. Science 2002;296:868-871
3. Saxena S, Caroni P. Mechanisms of axon degeneration: From development to disease. Prog Neurobiol 2007;83:174-191
4. Coleman M. Axon degeneration mechanisms: Commonality amid diversity. Nat Rev Neurosci 2005;6:889-898
5. Miller BR, Press C, Daniels RW, et al. A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration. Nat Neurosci 2009;12:387-389
6. Coleman MP, Perry VH. Axon pathology in neurological disease: A neglected therapeutic target. Trends Neurosci 2002;25:532-537
7. Vargas ME, Barres BA. Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci 2007;30:153-179
8. Lawson LJ, Frost L, Risbridger J, et al. Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve. J Neurocytol 1994;23:729-744
9. Beirowski B, Adalbert R, Wagner D, et al. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci 2005;6:6
10. Beirowski B, Berek L, Adalbert R, et al. Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice. J Neurosci Methods 2004;134:23-35
11. Ramon y Cajal S. Degeneration and Regeneration of the Nervous System. New York: Hafner, 1928
12. George R, Griffin JW. The proximo-distal spread of axonal degeneration in the dorsal columns of the rat. J Neurocytol 1994;23:657-667
13. Stokin GB, Lillo C, Falzone TL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005; 307:1282-1288
14. Adalbert R, Nogradi A, Babetto E, et al. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain 2008;132:402-416
15. Ohara S, Ukita Y, Ninomiya H, et al. Axonal dystrophy of dorsal root ganglion sensory neurons in a mouse model of Niemann-Pick disease type C. Exp Neurol 2004;187:289-298
16. Oya Y, Nakayasu H, Fujita N, et al. Pathological study of mice with total deficiency of sphingolipid activator proteins (SAP knockout mice). Acta Neuropathol 1998;96:29-40
17. Coleman MP, Adalbert R, Beirowski B. Neuroprotective strategies in MS: Lessons from C57BL/Wld(S) mice. J Neurol Sci 2005;233: 133-138
18. Takeuchi H, Mizuno T, Zhang G, et al. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J Biol Chem 2005;280:10444-10454
19. Komatsu M, Wang QJ, Holstein GR, et al. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc Natl Acad Sci USA 2007; 104:14489-14494
20. Maxwell WL, Povlishock JT, Graham DL. A mechanistic analysis of nondisruptive axonal injury: A review. J Neurotrauma 1997;14:419-440
21. Stone JR, Okonkwo DO, Dialo AO, et al. Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury. Exp Neurol 2004;190: 59-69
22. Pettus EH, Povlishock JT. Characterization of a distinct set of intra-axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability. Brain Res 1996;722: 1-11
23. Medana IM, Esiri MM. Axonal damage: A key predictor of outcome in human CNS diseases. Brain 2003;126:515-530
24. Kornek B, Storch MK, Bauer J et al. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2001;124:1114-1124
25. Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 1999;2:50-56
26. Ferreirinha F, Quattrini A, Pirozzi M, et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 2004;113:231-242
27. Wang QJ, Ding Y, Kohtz S, et al. Induction of autophagy in axonal dystrophy and degeneration. J Neurosci 2006;26:8057-8068
28. Nishiyama J, Miura E, Mizushima N, et al. Aberrant membranes and double-membrane structures accumulate in the axons of Atg5-null Purkinje cells before neuronal death. Autophagy 2007;3:591-596
29. Coleman MP, Conforti L, Buckmaster EA, et al. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc Natl Acad Sci USA 1998;95:9985-9990
30. Mack TG, Reiner M, Beirowski B, et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 2001;4:1199-1206
31. Lunn ER, Perry VH, Brown MC, et al. Absence of Wallerian degeneration does not hinder regeneration in peripheral Nerve. Eur J Neurosci 1989;1:27-33
32. Beirowski B, Babetto E, Coleman MP, et al. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model. Eur J Neurosci 2008;28:1166-1179
33. Perry VH, Brown MC, Lunn ER. Very slow retrograde and Wallerian degeneration in the CNS of C57BL/Ola mice. Eur J Neurosci 1991;3: 102-105
34. Ferri A, Sanes JR, Coleman MP, et al. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr Biol 2003;13:669-673
35. Howell GR, Libby RT, Jakobs TC, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol 2007;179:1523-1537
36. Sajadi A, Schneider BL, Aebischer P. Wld(s)-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr Biol 2004;14:326-330
37. Mi W, Beirowski B, Gillingwater TH, et al. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain 2005;128:405-416
38. Beirowski B, Babetto E, Gilley J, et al. Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo. J Neurosci 2009;29:653-668
39. Sasaki Y, Vohra BP, Baloh RH, et al. Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in vivo. J Neurosci 2009;29:6526-6534
40. Yahata N, Yuasa S, Araki T. Nicotinamide mononucleotide adenylyl-transferase expression in mitochondrial matrix delays Wallerian degeneration. J Neurosci 2009;29:6276-6284
41. Feng G, Mellor RH, Bernstein M, et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000;28:41-51
42. Perry VH, Brown MC, Tsao JW. The effectiveness of the gene which slows the rate of Wallerian degeneration in C57BL/Ola mice declines with age. Eur J Neurosci 1992;4:1000-1002
43. Misgeld T, Kerschensteiner M, Bareyre FM, et al. Imaging axonal transport of mitochondria in vivo. Nat Methods 2007;4:559-561
44. Stone JR, Singleton RH, Povlishock JT. Intra-axonal neurofilament compaction does not evoke local axonal swelling in all traumatically injured axons. Exp Neurol 2001;172:320-331
45. Cheng CL, Povlishock JT. The effect of traumatic brain injury on the visual system: A morphologic characterization of reactive axonal change. J Neurotrauma 1988;5:47-60
46. Edgar JM, McLaughlin M, Yool D, et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 2004;166:121-131
47. Griffiths I, Klugmann M, Anderson T, et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998;280:1610-1613
48. Pease ME, McKinnon SJ, Quigley HA, et al. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 2000;41:764-774
49. Kerschensteiner M, Schwab ME, Lichtman JW, et al. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med 2005;11:572-577
50. Mukoyama M, Yamazaki K, Kikuchi T, et al. Neuropathology of gracile axonal dystrophy (GAD) mouse. An animal model of central distal axonopathy in primary sensory neurons. Acta Neuropathol 1989; 79:294-299
51. Probst A, Gotz J, Wiederhold KH, et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol 2000;99:469-481
52. Tseng KW, Chau YP, Yang MF, et al. Abnormal cellular translocation of alpha-internexin in spinal motor neurons of Dystonia musculorum mice. J Comp Neurol 2008;507:1053-1064
53. Okamoto K, Hirai S, Shoji M, et al. Axonal swellings in the corticospinal tracts in amyotrophic lateral sclerosis. Acta Neuropathol 1990;80:222-226
54. Nixon RA. Autophagy in neurodegenerative disease: Friend, foe or turncoat? Trends Neurosci 2006;29:528-535
55. Rubinsztein DC, DiFiglia M, Heintz N, et al. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 2005;1:11-22
56. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998e;338:278-285
57. Ferguson B, Matyszak MK, Esiri MM, et al. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-399
58. Smith DH, Chen XH, Nonaka M, et al. Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J Neuropathol Exp Neurol 1999;58: 982-992 (Pubitemid 29441926)
59. Stone JR, Singleton RH, Povlishock JT. Antibodies to the C-terminus of the beta-amyloid precursor protein (APP): A site specific marker for the detection of traumatic axonal injury. Brain Res 2000;871:288-302
60. Wirths O, Weis J, Kayed R, et al. Age-dependent axonal degeneration in an Alzheimer mouse model. Neurobiol Aging 2007;28:1689-1699
61. Irvine KA, Blakemore WF. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 2006;175:69-76
62. Mancardi G, Hart B, Roccatagliata L, et al. Demyelination and axonal damage in a non-human primate model of multiple sclerosis. J Neurol Sci 2001;184:41-49
63. Saatman KE, Abai B, Grosvenor A, et al. Traumatic axonal injury results in biphasic calpain activation and retrograde transport impairment in mice. J Cereb Blood Flow Metab 2003;23:34-42
64. Yue Z, Wang QJ, Komatsu M. Neuronal autophagy: Going the distance to the axon. Autophagy 2008;4:94-96
65. Stys PK. General mechanisms of axonal damage and its prevention. J Neurol Sci 2005;233:3-13
66. McCarran WJ, Goldberg MP. White matter axon vulnerability to AMPA/kainate receptorYmediated ischemic injury is developmentally regulated. J Neurosci 2007;27:4220-4229
67. Waxman SG. Axonal conduction and injury in multiple sclerosis: The role of sodium channels. Nat Rev Neurosci 2006;7:932-941
68. Buki A, Farkas O, Doczi T, et al. Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury. J Neurotrauma 2003;20:261-268
69. 2+ channel activation of ryanodine receptors. Neuron 2003;40:53-63
70. LoPachin RM, Lehning EJ. Mechanism of calcium entry during axon injury and degeneration. Toxicol Appl Pharmacol 1997;143:233-244
71. Ren Y, Ridsdale A, Coderre E, et al. Calcium imaging in live rat optic nerve myelinated axons in vitro using confocal laser microscopy. J Neurosci Methods 2000;102:165-176
72. Nixon RA, Quackenbush R, Vitto A. Multiple calcium-activated neutral proteinases (CANP) in mouse retinal ganglion cell neurons: Specificities for endogenous neuronal substrates and comparison to purified brain CANP. J Neurosci 1986;6:1252-1263
73. Schlaepfer WW. Structural alterations of peripheral nerve induced by the calcium ionophore A23187. Brain Res 1977;136:1-9
74. Zhai Q, Wang J, Kim A, et al. Involvement of the ubiquitin-proteasome system in the early stages of Wallerian degeneration. Neuron 2003;39: 217-225
75. Iwata A, Stys PK, Wolf JA, et al. Traumatic axonal injury induces proteolytic cleavage of the voltage-gated sodium channels modulated by tetrodotoxin and protease inhibitors. J Neurosci 2004;24:4605-4613
76. Wolf JA, Stys PK, Lusardi T, et al. Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci 2001;21:1923-1930
77. Yang Y, Fukui K, Koike T, et al. Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons. Eur J Neurosci 2007;26:2979-2988
78. Stoll G, Griffin JW, Li CY, et al. Wallerian degeneration in the peripheral nervous system: Participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 1989;18:671-683
79. Ramaglia V, Wolterman R, de Kok M, et al. Soluble complement receptor 1 protects the peripheral nerve from early axon loss after injury. Am J Pathol 2008;172:1043-1052
80. Sievers C, Platt N, Perry VH, et al. Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neurosci Res 2003;46:161-169
81. + levels. Eur J Neurosci 1995;7:1596-1602
82. Nave KA, Trapp BD. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 2008;31:535-561
83. Pilling AD, Horiuchi D, Lively CM, et al. Kinesin-1 and Dynein are the primary motors for fast transport of mitochondria in Drosophila motor axons. Mol Biol Cell 2006;17:2057-2068
84. George EB, Glass JD, Griffin JW. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci 1995;15:6445-6452
85. Glass JD, Culver DG, Levey AI, et al. Very early activation of m-calpain in peripheral nerve during Wallerian degeneration. J Neurol Sci 2002;196:9-20
86. 2+ exchanger. J Neurosci 1996; 16:545-552
87. 2+ influx during anoxia in mammalian central nervous system white matter. Ann Neurol 1991;30:375-380
88. Teng YD, Wrathall JR. Local blockade of sodium channels by te-trodotoxin ameliorates tissue loss and long-term functional deficits resulting from experimental spinal cord injury. J Neurosci 1997;17:4359-4366
89. Araujo Couto L, Sampaio Narciso M, Hokoc JN, et al. Calpain inhibitor 2 prevents axonal degeneration of opossum optic nerve fibers. J Neurosci Res 2004;77:410-419
90. Waxman SG, Black JA, Ransom BR, et al. Protection of the axonal cytoskeleton in anoxic optic nerve by decreased extracellular calcium. Brain Res 1993;614:137-145
91. Tsao JW, Brown MC, Carden MJ, et al. Loss of the compound action potential: An electrophysiological, biochemical and morphological study of early events in axonal degeneration in the C57BL/Ola mouse. Eur J Neurosci 1994;6:516-524
92. Giordana MT, Richiardi P, Trevisan E, et al. Abnormal ubiquitination of axons in normally myelinated white matter in multiple sclerosis brain. Neuropathol Appl Neurobiol 2002;28:35-41
93. Liberski PP, Budka H. Neuroaxonal pathology in Creutzfeldt-Jakob disease. Acta Neuropathol 1999;97:329-334
94. Sasaki S, Iwata M. Immunoreactivity of beta-amyloid precursor protein in amyotrophic lateral sclerosis. Acta Neuropathol 1999;97:463-468
95. Moeller JJ, Macaulay RJ, Valdmanis PN, et al. Autosomal dominant sensory ataxia: A neuroaxonal dystrophy. Acta Neuropathol 2008;116: 331-336
96. Dewar D, Yam P, McCulloch J. Drug development for stroke: Importance of protecting cerebral white matter. Eur J Pharmacol 1999;375:41-50
97. Dikranian K, Cohen R, Mac Donald C, et al. Mild traumatic brain injury to the infant mouse causes robust white matter axonal degeneration which precedes apoptotic death of cortical and thalamic neurons. Exp Neurol 2008;211:551-560
98. Medana I, Martinic MA, Wekerle H, et al. Transection of major histocompatibility complex class IYinduced neurites by cytotoxic T lymphocytes. Am J Pathol 2001;159:809-815
99. Wirths O, Weis J, Szczygielski J, et al. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathol 2006;111:312-319
100. Valverde F. Golgi Atlas of the Postnatal Mouse Brain. Vienna: Springer, 1998